Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.72 |
| ▸ | CASP1 | P29466 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | CES2 | O00748 | 1/20 | 0.72 |
| ▸ | GALR3 | O60755 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | GSTA1 | P08263 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30352763 | 1.00 | CYP2C9 (0.72) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL9487167 | 0.98 | CYP2C9 (0.69) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| Acetic Acid SCHEMBL29404037 | 0.94 | CYP2C9 (0.64) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| Acetic Acid SCHEMBL25029 | 0.94 | CYP2C9 (0.64) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| 1,4-Butanediol SCHEMBL11023193 | 0.89 | CYP2C9 (0.58) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL29355897 | 0.84 | CES2 (1.00) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL2156880 | 0.84 | CES2 (1.00) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL15684683 | 0.84 | ALOX15 (1.00) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL21812547 | 0.83 | GSTA1 (0.77) | CYP2C9HPGDALOX15CASP1CYP2C19 | |
| SCHEMBL467470 | 0.82 | ALDH1A1 (0.61) | CYP2C9HPGDALOX15CASP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| CN-120082479-A | Composite bacterium for biological strengthening and sludge reduction and preparation method thereof | 无锡映川环境技术有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120058783-A | Preparation method and application of tris (2-methyl-2-phenylpropyl) tin 5-bromosalicylate complex | 衡阳师范学院 | 2025-05-30 | — | — | CN | claimed |
| CN-120058781-A | Preparation method and application of tricyclohexyltin 5-bromosalicylate complex | 衡阳师范学院 | 2025-05-30 | — | — | CN | claimed |
| EP-4352449-B1 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECH INC (US) | 2025-05-07 | — | — | EP | claimed |
| CN-119684323-A | Zinc complex and preparation method thereof | 桂林师范高等专科学校 | 2025-03-25 | — | — | CN | claimed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| CN-119308038-A | Preparation method and application of photochromic dye modified spandex fiber | 湖北省不挽离人科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118619869-B | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118973990-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | claimed |
| US-4567019-A | RAPID, REVERSIBLE THERMOCHROMISM | GRAPHIC CONTROLS CORPORATION (US) | 1986-01-28 | — | — | US | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | CYP2C9 356/4885HPGD 441/4885ALOX15 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.